The AGU Fall Meeting is the largest earth and space ...
Improvements to the BioTrak® Real-Time Viable Particle Counter, a biofluorescent particle counter, to remove roadblocks to pharmaceutical market acceptance are here. Join webinar that will highlight updates to the instrument.
Date — October 19, 2021
Time — 8:00 a.m. CDT (1 hour, includes 15 min for Q&A)
Location — Webex Event
Click HERE or on the button below to register to attend.
Dr. Patrick Hutchins is a Global Product Manager at TSI Inc. where he supports and develops pharmaceutical manufacturing products. He earned his PhD in Pharmacology at the University of Colorado in 2012. His thesis focused on chromatography, mass spectrometry and related bioanalytical techniques. Dr. Hutchins has spent his entire post-academic career working with airborne particle instrumentation and has been with TSI since 2015.
Mike Dingle is a Senior Application Specialist at TSI where he provides application support for the BioTrak Real-Time Viable Particle Counter and other TSI products used to test and monitor controlled environments. Prior to joining TSI, Mike worked as a QC Microbiologist in the pharmaceutical and medical device industries for over 20 years where he developed and managed environmental monitoring programs for a wide variety of controlled environments.
CLICK HERE to check out application note CC-129: Improved Viable Particle Discrimination for Pharma that describes the performance of a new algorithm developed for use by the BioTrak Real-Time Viable Particle Counter to determine the viability of a particle based on its measured optical properties.
TSI Incorporated provides a complete range of solutions for cleanroom applications used by national and standard laboratories worldwide. TSI´s cutting edge solutions help customers ensure regulatory compliance and improve quality of products dedicated to pharmaceutical manufacturing.